RxDoctor Payments Data

Kazim Mohammed, PA

Physician Assistant · Fort Myers, FLNPI 1467911040

Payments from drug & device makers

$7,762in general payments, 2019–2025

Across 423 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Supernus Pharmaceuticals, Inc.$819
  • Teva Pharmaceuticals USA, Inc.$529
  • Alkermes, Inc.$478
  • Corium, LLC$478
  • plus $3K from 17 others

What the payments were for

  • Food & beverage$7,71699%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,762 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$37,117
Medicare patients
57
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine13$62,184
VraylarCariprazine Hcl19$26,733
TrintellixVortioxetine Hydrobromide16$9,446
Buspirone Hcl218$4,180
Aripiprazole88$3,343
Quetiapine Fumarate ErQuetiapine Fumarate28$3,045
Bupropion XlBupropion Hcl162$2,582
Mirtazapine190$2,354
Hydroxyzine Hcl89$2,253
Gabapentin28$1,712
Venlafaxine Hcl ErVenlafaxine Hcl133$1,499
Desvenlafaxine Succinate ErDesvenlafaxine Succinate21$1,498
Sertraline Hcl207$1,312
Olanzapine39$1,181
Duloxetine Hcl63$899

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$529$62,18413 claims
AbbVieVraylar$1,270$26,73319 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$122$9,44616 claims
Almatica Pharma LLCSertraline Hcl$143$1,312207 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →